Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck CancerMarshall R. Posner, Robert I. Haddad, Roy B. Tishler et al.|New England Journal of Medicine|2007Cited by 1.7k
Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trialMarshall R. Posner, Kevin J. Cullen, Jochen H. Lorch et al.|Annals of Oncology|2011Cited by 487
Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trialJochen H. Lorch, Marshall R. Posner, Olga Goloubeva et al.|The Lancet Oncology|2011Cited by 447
Racial Survival Disparity in Head and Neck Cancer Results from Low Prevalence of Human Papillomavirus Infection in Black Oropharyngeal Cancer PatientsKathleen Settle, Kevin J. Cullen, Marshall R. Posner et al.|Cancer Prevention Research|2009Cited by 297
Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservationMarshall R. Posner, Robert I. Haddad, Charles M. Norris et al.|Annals of Oncology|2009Cited by 152